Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.99
Delayed Data
As of Jan 13
 +0.71 / +1.16%
Today’s Change
50.71
Today|||52-Week Range
68.12
-1.01%
Year-to-Date
Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan 13 / Zacks.com - Paid Partner Content
Atalanta Sosnoff Capital, Llc Buys Anadarko Petroleum Corp, Morgan Stanley, Norfolk S...
Jan 10 / GuruFocus News - Paid Partner Content
Biotech Just Got Trumped
Jan 12 / TheStreet.com - Paid Partner Content
10 Stocks for Using a Benjamin Graham Value Investing Strategy
Jan 10 / GuruFocus News - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
AbbVie's HCV Combo Favorable in Japanese Phase III Study
Jan 10 / Zacks.com - Paid Partner Content
7 Reasons AbbVie's Stock Could Soar in 2017
Jan 12 / MotleyFool.com - Paid Partner Content
Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised)
Jan 09 / Zacks.com - Paid Partner Content
First Dallas Securities Inc. Buys Mylan NV, Forterra Inc, American Express Co, Sells ...
Jan 11 / GuruFocus News - Paid Partner Content
Will Johnson & Johnson Shock Investors with a Spin-off in 2017?
Jan 08 / MotleyFool.com - Paid Partner Content
Entana Pharmaceuticals Releases Study Results of Hepatitis Treatment in Japanese Pati...
Jan 11 / GuruFocus News - Paid Partner Content
Pfizer's Humira Biosimilar Meets Primary Endpoint in Study
Jan 06 / Zacks.com - Paid Partner Content
Entana Pharmaceuticals Releases Results of AbbVie Hepatitis Treatment in Japanese Pat...
Jan 11 / GuruFocus News - Paid Partner Content
Gilead Sciences Inc.'s Biggest Failure in 2016
Jan 05 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
6 Top Stocks to Buy in January
Jan 03 / MotleyFool.com - Paid Partner Content
Pfizer Inc.: Humira's Biosimilar Meets Primary Endpoint
Jan 10 / GuruFocus News - Paid Partner Content